Susquehanna International Group
OTLK icon

Susquehanna International Group’s Outlook Therapeutics OTLK Stock Holding History

Susquehanna International Group’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.6K Sell
134,084
-37,938
-22% -$16.4K ﹤0.01% 12790
2025
Q4 		$272K Sell
172,022
-39,399
-19% -$63K ﹤0.01% 10181
2025
Q3 		$224K Buy
211,421
+93,652
+80% +$162K ﹤0.01% 10738
2025
Q2 		$188K Buy
117,769
+46,847
+66% +$74.7K ﹤0.01% 11274
2025
Q1 		$86.5K Sell
70,922
-10,353
-13% -$18.2K ﹤0.01% 11621
2024
Q4 		$154K Buy
+81,275
New +$334K ﹤0.01% 10997
2024
Q3 		– Sell
-15,678
Closed -$115K – 12745
2024
Q2 		$116K Buy
+15,678
New +$126K ﹤0.01% 10911
2024
Q1 		– Sell
-2,664
Closed -$21K – 13018
2023
Q4 		$21K Buy
+2,664
New +$22.5K ﹤0.01% 11965
2023
Q3 		– Sell
-2,711
Closed -$94.3K – 12700
2023
Q2 		$94.3K Sell
2,711
-1,709
-39% -$46.6K ﹤0.01% 10992
2023
Q1 		$96.3K Buy
4,420
+3,345
+311% +$74.8K ﹤0.01% 11322
2022
Q4 		$23.2K Sell
1,075
-720
-40% -$15.7K ﹤0.01% 11710
2022
Q3 		$44K Buy
+1,795
New +$41.7K ﹤0.01% 12285
2022
Q2 		– Sell
-921
Closed -$33K – 13649
2022
Q1 		$33K Buy
+921
New +$28.8K ﹤0.01% 12475
2021
Q2 		– Sell
-8,292
Closed -$373K – 13060
2021
Q1 		$373K Buy
+8,292
New +$318K ﹤0.01% 10138
2020
Q1 		– Sell
-585
Closed -$7K – 10702
2019
Q4 		$7K Sell
585
-243
-29% -$5.66K ﹤0.01% 9567
2019
Q3 		$25K Buy
+828
New +$31.9K ﹤0.01% 9921
2019
Q1 		– Sell
-712
Closed -$57K – 9562
2018
Q4 		$57K Sell
712
-257
-27% -$31.6K ﹤0.01% 8436
2018
Q3 		$152K Buy
+969
New +$136K ﹤0.01% 8407
2018
Q2 		– Sell
-211
Closed -$30K – 10155
2018
Q1 		$30K Buy
+211
New +$37.7K ﹤0.01% 9072

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Susquehanna International Group's OTLK Position: Q1 2026 in Review

Susquehanna International Group reduced its Outlook Therapeutics (OTLK) stake by 22% in Q1 2026, selling an estimated $16.4K and leaving 134,084 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #12790.

Susquehanna International Group first reported a position in OTLK in Q1 2018 and has held it in 19 quarters since. The position peaked at $373K in Q1 2021. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Susquehanna International Group held 134,084 shares of Outlook Therapeutics worth $27.6K as of Q1 2026.
  • Susquehanna International Group sold 37,938 Outlook Therapeutics shares in Q1 2026, an estimated $16.4K.
  • Outlook Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12790 holding.
  • Susquehanna International Group first reported a position in Outlook Therapeutics in Q1 2018 and has held it in 19 quarters since.
  • Susquehanna International Group's Outlook Therapeutics position peaked at $373K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.